SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brian Moore who wrote (17642)3/18/1998 8:25:00 PM
From: Andreas Helke  Read Replies (1) of 32384
 
I have identified Ligand as a candidate for that superior earnings driven long term growth. Of course you have to wait at least till 99 for positive earnings. But after that Ligand has a good chance to deliver the earnings growth that you are speaking about. Of course the business risk of a biotech is higher than that of a stock like Coca Cola. But I think the investment risk is not that different. Ligand shares will go down 50% on bad news or even for no particular reason. But the price will go up again in a reasonable time frame.
With Coca Cola investors are paying a big premium for dependable growth. But if investors decide to pay less of a premium then the price will go down and it can take years to get ones money back. In contrast to Ligand Coca Cola can not compensate a lower P/E multiple with a superior earnings growth rate to get its share price up again.

And the important thing is with Ligand you start with an undervalued stock while the good growth stocks are often very expensive.

Andreas
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext